In a pioneering regenerative med study, scientists get a green light to test iPS cells for spinal cord damage
Another world’s first in the use of induced pluripotent stem cells is getting underway in Japan.
Just a few months after the world’s first Parkinson’s patient was given a pioneering iPS transplant at Kyoto University, another university team has come back and won a green light to try and see if they can use the same approach to regenerate nerve cells damaged by a spinal cord injury.
Japanese health authorities have approved a pitch by a team of scientists at Keio University to transplant a batch of 2 million iPS cells into 4 patients. That dose can later be upped provided it appears to be safe.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
